Filing Details
- Accession Number:
- 0000711377-19-000032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-07 11:01:28
- Reporting Period:
- 2019-08-05
- Accepted Time:
- 2019-08-07 11:01:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651434 | Edward John Adent | 822 7Th Street, Suite 740 Greeley CO 80631 | President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-05 | 40,002 | $51.29 | 44,302 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-08-05 | 31,489 | $69.03 | 12,813 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock (Right to Buy) | Disposition | 2019-08-05 | 40,002 | $0.00 | 40,002 | $51.29 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
149,999 | 2022-08-17 | No | 4 | M | Direct |
Footnotes
- Options were granted on 7/17/2017, have five year lives and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
- Mr. Adent sold these shares to cover the cost of the exercise